CPC A61K 31/4439 (2013.01) [A61K 9/08 (2013.01); A61K 9/16 (2013.01); A61K 9/20 (2013.01); A61K 9/48 (2013.01); A61P 1/16 (2018.01)] | 13 Claims |
1. A method of treating nonalcoholic fatty liver disease, comprising administering to a subject in need thereof a dosage form comprising an effective amount of a compound of formula (1)
or a pharmaceutically acceptable salt thereof, wherein the nonalcoholic fatty liver disease is nonalcoholic steatohepatitis.
|